These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11001886)

  • 21. Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.
    Schindewolf M; Steindl J; Beyer-Westendorf J; Schellong S; Dohmen PM; Brachmann J; Madlener K; Pötzsch B; Klamroth R; Hankowitz J; Banik N; Eberle S; Müller MM; Kropff S; Lindhoff-Last E
    J Am Coll Cardiol; 2017 Nov; 70(21):2636-2648. PubMed ID: 29169470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heparin-induced thrombocytopenia (HIT): in vitro and in vivo cross-reactivity to danaparoid sodium and successful treatment with recombinant hirudin (lepirudin).
    Baumgärtel MW; Eichler P; Glöckner WM; Ranze O; Greinacher A
    Eur J Haematol; 2000 Aug; 65(2):148-9. PubMed ID: 10966178
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of bivalirudin to lepirudin and argatroban in patients with heparin-induced thrombocytopenia.
    Bain J; Meyer A
    Am J Health Syst Pharm; 2015 Sep; 72(17 Suppl 2):S104-9. PubMed ID: 26272889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of direct thrombin inhibitors in cardiovascular surgery in patients with heparin-induced thrombocytopenia.
    Greinacher A
    Semin Thromb Hemost; 2004 Jun; 30(3):315-27. PubMed ID: 15282654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis.
    Fischer KG; van de Loo A; Böhler J
    Kidney Int Suppl; 1999 Nov; (72):S46-50. PubMed ID: 10560805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new therapeutic option by subcutaneous recombinant hirudin in patients with heparin-induced thrombocytopenia type II: a pilot study.
    Huhle G; Hoffmann U; Hoffmann I; Liebe V; Harenberg JF; Heene DL
    Thromb Res; 2000 Aug; 99(4):325-34. PubMed ID: 10963783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interference of thrombin in immunological assays for hirudin specific antibodies.
    Hamilton RG; Levy JH; Marder VJ; Sane DC
    J Immunol Methods; 2012 Jul; 381(1-2):50-8. PubMed ID: 22542931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of ecarin clotting time (ECT) with lepirudin therapy in heparin-induced thrombocytopenia and cardiopulmonary bypass.
    Fabrizio MC
    J Extra Corpor Technol; 2001 May; 33(2):117-25. PubMed ID: 11467439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lepirudin for therapeutic use in heparin-induced thrombocytopenia].
    Harenberg J; Jörg I; Koch S; Fenyvesi T
    Hamostaseologie; 2004 May; 24(2):135-43. PubMed ID: 15136878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repetitive intraoperative use of recombinant hirudin (Lepirudin) in peripheral vascular surgery with HITT.
    Goti F; Korte W; Sege D
    Swiss Med Wkly; 2001 Dec; 131(47-48):693-4. PubMed ID: 11875754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of direct thrombin inhibitors in the treatment of Heparin-Induced Thrombocytopenia: a single institution experience.
    Curzio KM; Cheng-Lai A; Kheyfets V; Sinnet M; Billett HH
    J Thromb Thrombolysis; 2009 Aug; 28(2):117-23. PubMed ID: 18827975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies against lepirudin are polyspecific and recognize epitopes on bivalirudin.
    Eichler P; Lubenow N; Strobel U; Greinacher A
    Blood; 2004 Jan; 103(2):613-6. PubMed ID: 14512301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment options for heparin-induced thrombocytopenia.
    Greinacher A
    Am J Health Syst Pharm; 2003 Oct; 60 Suppl 5():S12-8. PubMed ID: 14593978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anaphylactic and anaphylactoid reactions associated with lepirudin in patients with heparin-induced thrombocytopenia.
    Greinacher A; Lubenow N; Eichler P
    Circulation; 2003 Oct; 108(17):2062-5. PubMed ID: 14568897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lepirudin for heparin-induced thrombocytopenia.
    Med Lett Drugs Ther; 1998 Sep; 40(1036):94-5. PubMed ID: 9774965
    [No Abstract]   [Full Text] [Related]  

  • 36. Atypical heparin-induced thrombocytopenia complicated by intracardiac thrombus, effectively treated with ultra-low-dose rt-PA lysis and recombinant hirudin (Lepirudin).
    Olbrich K; Wiersbitzky M; Wacke W; Eichler P; Zinke H; Schwock M; Möx B; Kraatz G; Motz W; Greinacher A
    Blood Coagul Fibrinolysis; 1998 Apr; 9(3):273-7. PubMed ID: 9663711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevention of thrombosis with subcutaneous recombinant hirudin in heparin-induced thrombocytopenia type II. A pilot study].
    Huhle G; Hoffmann U; Hoffmann I; Harenberg J; Heene DL
    Dtsch Med Wochenschr; 2000 Jun; 125(22):686-91. PubMed ID: 10874895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of lepirudin for anticoagulation in patients with heparin-induced thrombocytopenia during major vascular surgery.
    Sun Y; Greilich PE; Wilson SI; Jackson MR; Whitten CW
    Anesth Analg; 2001 Feb; 92(2):344-6. PubMed ID: 11159229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant hirudin in clinical practice: focus on lepirudin.
    Greinacher A; Lubenow N
    Circulation; 2001 Mar; 103(10):1479-84. PubMed ID: 11245656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Point of care measurement of lepirudin and heparin anticoagulation during systemic inflammation.
    Homoncik M; Pernerstorfer T; Reiter R; Knechtelsdorfer M; Quehenberger P; Jilma B
    Thromb Res; 2002 Oct; 108(1):91-5. PubMed ID: 12586138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.